Home › Funds › PFM Health Sciences, LP › ELAN

PFM Health Sciences, LP position in ELAN

ELANCO ANIMAL HEALTH INC · Health Care

PFM Health Sciences, LP reported holding 344,946 shares of ELAN (ELANCO ANIMAL HEALTH INC) in its Q3 2026 13F filing — a position valued at US$7.7M, representing 0.79% of its reported portfolio and ranking #46 among its reported holdings. PFM Health Sciences, LP has disclosed ELAN holdings in 3 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)344.95K sh
Reported value held$7.72M
Portfolio Weight0.79%
First reportedQ4 2025
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's ELAN position evolved

PFM Health Sciences, LP first disclosed a stake in ELAN in Q4 2025 at 207,311 shares (US$4.7M). The position peaked in Q3 2026 at 344,946 shares, worth US$7.7M. Across 3 filings, PFM Health Sciences, LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 344,946 shares valued at US$7.7M — an increase of 172,457 shares quarter over quarter.. Notable position changes include a 100% increase in Q3 2026 (shares rose 20% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 207.31K $4.69M New
Q2 2026 172.49K $4.24M New
Q3 2026 344.95K $7.72M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELAN and 13F data

ELAN (ELANCO ANIMAL HEALTH INC) is a Health Care company. 30 other funds we track also report a position in ELAN — the largest reported positions include Dodge & Cox (US$1.66B), PRIMECAP MANAGEMENT CO/CA/ (US$1.02B), T. Rowe Price Investment Management, Inc. (US$707.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELAN

All ELAN fund holders →

FAQ

How long has PFM Health Sciences, LP held ELAN?

PFM Health Sciences, LP has disclosed ELAN holdings in 3 of the last 4 reported quarters, going back to Q4 2025.

What is PFM Health Sciences, LP's current position in ELAN?

As of Q3 2026, PFM Health Sciences, LP holds 344.95K shares of ELAN (ELANCO ANIMAL HEALTH INC), valued at $7.72M, representing 0.79% of its reported portfolio and ranking #46.

Has PFM Health Sciences, LP been buying or selling ELAN?

In the latest 13F filing (Q3 2026), PFM Health Sciences, LP increased its position in ELAN. The position peaked in Q3 2026 at 344.95K shares.

Which other funds hold ELAN?

Other major institutional holders of ELAN include Dodge & Cox, PRIMECAP MANAGEMENT CO/CA/, T. Rowe Price Investment Management, Inc., among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.